Mylan Laboratories Limited Rivaroxaban Export Data — India (DGFT 2022–2026)

Name: Mylan Laboratories Limited Rivaroxaban Export Records India — #1 Exporter, 257 Shipments, $12.8M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Rivaroxaban

India Pharmaceutical Trade Intelligence

$52.6M221 Suppliers115 CountriesHS 30049099

ExportsIndia → NETHERLANDS29.9%India → MALTA9.6%

ImportsGERMANY → India$34.1B CANADA → India$46.0K

#1 Supplier: MYLAN LABORATORIES #1 Buyer: MYLAN IRELAND

Mylan Laboratories Limited — Rivaroxaban Exporter #1 | $12.8M Trade Value | TransData Nexus | TransData Nexus

Mylan Laboratories Limited — Rivaroxaban Exporter Profile

Indian Pharmaceutical Exporter · #1 for Rivaroxaban · $12.8M export value · DGFT Verified

Mylan Laboratories Limited is the #1 Indian exporter of Rivaroxaban with $12.8M in export value and 257 verified shipments. Mylan Laboratories Limited holds a 24.4% market share in Rivaroxaban exports across 11 countries. The company exports 91 pharmaceutical products worth $634.8M across 26 therapeutic categories.

Mylan Laboratories Limited — Rivaroxaban Export Profile: Buyers & Destinations

Mylan Laboratories Limited Rivaroxaban export treemap — buyers and destination countries | TransData Nexus

Where Does Mylan Laboratories Limited Export Rivaroxaban?

Country	Value	Shipments	Share
NETHERLANDS	$3.3M	195	77.1%
FRANCE	$435.2K	16	10.0%
ZIMBABWE	$272.8K	10	6.3%
THAILAND	$128.3K	9	3.0%
BELGIUM

Who Are the Top Buyers of Rivaroxaban from Mylan Laboratories Limited?

Buyer	Country	Value	Orders
MYLAN IRELAND C/O ALLOGA RDC,	NETHERLANDS	$1.5M	83
MYLAN IRELAND C/O ALLOGA RDC,.	NETHERLANDS	$617.9K	46
MYLAN IRELAND	NETHERLANDS	$565.2K	33
MYLAN IRELAND C/O ALLOGA RDC	NETHERLANDS	$259.2K	15
CSP VIATRIS SANTE AT CSP- LABO,	FRANCE	$241.1K	12
CSP	FRANCE	$204.6K	5
REMED PRIVATE LIMITED	ZIMBABWE	$175.9K	6
MYLAN IRELAND C O ALLOGA RDC	NETHERLANDS	$138.5K	7
VIATRIS PHARMACEUTICALS (THAILAND)	THAILAND	$128.3K	9
BGP PRODUCTS GMBH,	NETHERLANDS	$92.3K	4

Mylan Laboratories Limited supplies Rivaroxaban to 23 buyers globally. The largest buyer is MYLAN IRELAND C/O ALLOGA RDC, (NETHERLANDS), followed by MYLAN IRELAND C/O ALLOGA RDC,. (NETHERLANDS) and MYLAN IRELAND (NETHERLANDS). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Rivaroxaban Formulations Does Mylan Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
RIVAROXABAN VIATRIS 20 MG 28BL PACKS 2X14 S BLISTER 274358 PACKS X 2X14 S 7682024 NOS	$100.0K	2
RIVAROXABAN TAB 20MG 100BT FI/SE VIA PACKS 26233NOS	$83.5K	3
RIVAROXABAN TAB 20MG 10BL SSA MY 1 X 10S BLISTER	$75.5K	2
RIVAROXABAN TAB 10MG 30BL FR VIA (PACKS 3 X 10S BLISTER)(73105 PACKS X 3X10S=2193150 NOS)NOS	$55.6K	3
RIVAROXABAN TAB 10MG 10BL SSA MY 1 X 10S BLISTER	$51.3K	2
HARMLESS MEDICINES RIVAROXABAN VIATRIS20 MG 28BL TAB 29837 PACKS	$50.0K	1
HARMLESS MEDICINES RIVAROXABAN VIATRIS20 MG 28BL TAB 39639 PACKS	$50.0K	1
HARMLESS MEDICINES RIVAROXABANO ANOVA 20 MG 28BL TAB 39585 PACKS	$50.0K	1
HARMLESS MEDICINES RIVAROXABAN TAB 15MG42BL PT VIA 28605 PACKS	$50.0K	1
HARMLESS MEDICINES, RIVAROXABAN TAB 10MG30BL IE VIA (2760 PACKS)	$50.0K	1

Mylan Laboratories Limited exports 214 distinct Rivaroxaban formulations including tablets, capsules, syrups, and combination drugs. The top formulation is RIVAROXABAN VIATRIS 20 MG 28BL PACKS 2X14 S BLISTER 274358 P with 2 shipments worth $100.0K.

How Does Mylan Laboratories Limited Compare to Nearest Rivaroxaban Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	MYLAN LABORATORIES LIMITED ★	$12.8M	257	11	$50.0K
2	DR.REDDY'S LABORATORIES LTD	$5.2M	131	12	$39.6K
3	ZENTIVA PRIVATE LIMITED	$3.2M	148	2	$21.5K

Mylan Laboratories Limited ranks #1 among 221 Indian Rivaroxaban exporters. Average shipment value of $50.0K compared to the market average of $166.0K. The closest competitors by value are DR.REDDY'S LABORATORIES LTD and ZENTIVA PRIVATE LIMITED.

Which Indian Ports Ship Rivaroxaban Exports?

Port	Shipments	% Share
SAHAR AIR	1,144	21.3%
DELHI AIR CARGO ACC (INDEL4)	985	18.4%
DELHI AIR	659	12.3%
SAHAR AIR CARGO ACC (INBOM4)	635	11.8%
Bombay Air	197	3.7%
NHAVA SHEVA SEA (INNSA1)	164	3.1%
Delhi Air	133	2.5%
HYDERABAD AIR	110	2.1%

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Rivaroxaban Exports

Mylan's export operations are influenced by a complex geopolitical landscape. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended transit times. Major shipping lines have implemented 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU, directly impacting the cost structure for Indian pharmaceutical exporters like Mylan. Additionally, diversions around the Cape of Good Hope have further elongated delivery schedules, posing challenges to time-sensitive pharmaceutical shipments.

In the United States, the imposition of tariffs on pharmaceutical imports has prompted Indian companies to reassess their market strategies. While generics have largely remained exempt, the potential for future tariff expansions necessitates vigilance. Mylan, along with other Indian exporters, is exploring market diversification to mitigate reliance on the U.S. market. The recent India-European Union Free Trade Agreement (FTA), signed in January 2026, offers a strategic avenue for expansion. The FTA eliminates tariffs on approximately 97% of EU tariff lines, including pharmaceuticals, thereby enhancing market access for Indian exporters. This agreement is expected to significantly boost India's pharmaceutical exports to Europe, providing a counterbalance to uncertainties in the U.S. market.

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Mylan. The FDA's warning letter and import alert in December 2024 concerning the Indore facility underscore the critical importance of stringent quality control measures. The cited violations, including subpar quality control and improper management of manufacturing defects, have necessitated comprehensive corrective actions. Mylan's proactive response aims to restore compliance and reinforce its commitment to quality assurance.

The evolving regulatory environment, particularly in the European Union, further emphasizes the need for adherence to Good Manufacturing Practices (GMP). The EU's Falsified Medicines Directive mandates rigorous compliance to ensure product integrity and patient safety. For Mylan, aligning with these standards is essential to maintain and expand its foothold in the European market.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Rivaroxaban shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Mylan Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 257 individual customs records matching Mylan Laboratories Limited exporting Rivaroxaban, covering 214 formulations to 11 countries via 23 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 115+ countries, 497+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Rivaroxaban

Rivaroxaban

Mylan Laboratories Limited — Rivaroxaban Exporter Profile

Mylan Laboratories Limited — Rivaroxaban Export Profile: Buyers & Destinations

Where Does Mylan Laboratories Limited Export Rivaroxaban?

Who Are the Top Buyers of Rivaroxaban from Mylan Laboratories Limited?

What Is India's Total Rivaroxaban Export Value and How Much Does Mylan Laboratories Limited Contribute?

What Is the Average Shipment Value for Mylan Laboratories Limited's Rivaroxaban Exports?

How Does Mylan Laboratories Limited Compare to Other Indian Rivaroxaban Exporters?

What Rivaroxaban Formulations Does Mylan Laboratories Limited Export?

How Does Mylan Laboratories Limited Compare to Nearest Rivaroxaban Exporters?

Which Indian Ports Ship Rivaroxaban Exports?

What Other Cardiovascular Products Does Mylan Laboratories Limited Export?

Rivaroxaban — Export Intelligence Video

Geopolitical & Trade Policy Impact on Mylan Laboratories Limited's Rivaroxaban Exports

Mylan Laboratories Limited — Regulatory Compliance & Quality Standards

About Mylan Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Rivaroxaban Export Data from Mylan Laboratories Limited

Rivaroxaban Stats

Company Overview

Top Products by Mylan Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source